Akela Pharma Inc. Reports Results for the Third Quarter of Fiscal 2008
MONTREAL, Nov. 14 /CNW Telbec/ - Akela Pharma Inc. (TSX: AKL), a drug
development company focused on developing therapies for the inhalation and
pain markets, today announced its financial results for the three and nine
months ended September 30, 2008.